Pharma News
Ulixacaltamide by Praxis Precision Medicines for Essential Tremor: Likelihood of Approval
Ulixacaltamide is under clinical development by Praxis Precision Medicines and currently in Phase III for Essential Tremor.
Source link
#Ulixacaltamide #Praxis #Precision #Medicines #Essential #Tremor #Likelihood #Approval